Although this could have suggested functional redundancy, the reported roles of these kinases in cancer widely differ, with RSK1 and RSK2 being considered tumour promoters, while RSK3 is generally thought as a tumour suppressor, and the role of RSK4 remains a matter for debate [8,9,10,11,12,13]. The gene discussed is RPS6KA3; the disease is neoplasm.